Table 1.
Summary of Regions Targeted for Optogenetic Control of Seizures In Vivoa
Target region | Promoter | Cell type | Opsin | Model | Effect | Reference |
---|---|---|---|---|---|---|
Motor cortex | CamKII | Glutamatergic | NpHR | Intracortical tetanus toxin | Reduced frequency of epileptiform events | Wykes et al., 2012 |
Ventrobasal thalamus | CamKII | Glutamatergic | NpHR | Photothrombotic stroke | Reduces power of epileptic events | Paz et al., 2013 |
Hippocampus | CamKII | Glutamatergic | NpHR | Systemic pilocarpine‐induced SE | Delayed SE onset by 5 min | Sukhotinsky et al., 2013 |
Ipsilateral hippocampus CA1 | PV | GABAergic | ChR2 | Intrahippocampal KA spontaneous seizures | Reduces seizure duration | Krook‐Magnuson et al., 2013 |
Contralateral hippocampus CA1 | PV | GABAergic | ChR2 | Intrahippocampal KA spontaneous seizures | Reduces seizure duration | Krook‐Magnuson et al., 2013 |
Ipsilateral hippocampus CA1 | CamKII | Glutamatergic | NpHR | Intrahippocampal KA spontaneous seizures | Reduces seizure duration | Krook‐Magnuson et al., 2013 |
Ipsilateral cerebellum | PV | GABAergic | ChR2 | Intrahippocampal KA spontaneous seizures | Reduces seizure duration | Krook‐Magnuson et al., 2014 |
Contralateral cerebellum | PV | GABAergic | ChR2 | Intrahippocampal KA spontaneous seizures | Reduces seizure duration | Krook‐Magnuson et al., 2014 |
Ipsilateral cerebellum | PV | GABAergic | NpHR | Intrahippocampal KA spontaneous seizures | Reduces seizure duration | Krook‐Magnuson et al., 2014 |
Contralateral cerebellum | PV | GABAergic | NpHR | Intrahippocampal KA spontaneous seizures | Reduces seizure duration | Krook‐Magnuson et al., 2014 |
Midline cerebellum (vermis) | PV | GABAergic | ChR2 | Intrahippocampal KA spontaneous seizures | Reduces seizure duration and increase time to next seizure | Krook‐Magnuson et al., 2014 |
Midline cerebellum (vermis) | PV | GABAergic | NpHR | Intrahippocampal KA spontaneous seizures | No effect on time to next seizure | Krook‐Magnuson et al., 2014 |
Hippocampus | PV | GABAergic | NpHR | Intrahippocampal KA spontaneous seizures | No effect | Krook‐Magnuson et al., 2014 |
Deep cerebellar nuclei | PV | GABAergic | ChR2 | Intrahippocampal KA spontaneous seizures | Reduces seizure duration and increase time to next seizure | Krook‐Magnuson et al., 2014 |
Purkinje neurons in ipsilateral cerebellum | Pcp2 | Purkinje (GABAergic) | ChR2 | Intrahippocampal KA spontaneous seizures | Reduces seizure duration | Krook‐Magnuson et al., 2014 |
Hippocampus | Thy1 | Panneuronal | ChR2 | 4‐AP intrahippocampal | Seizure activity (signal power) during stimulation reduced by 80% but does not stop events | Chiang et al., 2014 |
Hippocampus | hSyn | Panneuronal | NpHR | Intrahippocampal Bicuculline | Reduced bursting frequency | Berglind et al., 2014 |
Ventrobasal thalamus | CamKII | Glutamatergic | NpHR | Penicillin in somatosensory cortex | No effect | Han et al., 2015 |
Ipsilateral dentate gyrus | Pomc | Granule cell | NpHR | Intrahippocampal KA spontaneous seizures | Reduces seizure duration | Krook‐Magnuson et al., 2015 |
Contralateral dentate gyrus | Pomc | Granule cell | NpHR | Intrahippocampal KA spontaneous seizures | No effect | Krook‐Magnuson et al., 2015 |
Ipsi/contralateral dentate gyrus | Pomc | Granule cell | ChR2 | Intrahippocampal KA spontaneous seizures | Increased seizure severity | Krook‐Magnuson et al., 2015 |
Superior colliculus | hSyn | Panneuronal | ChR2 | Systemic PTZ | Reduced seizure severity | Soper et al., 2015 |
Superior colliculus | hSyn | Panneuronal | ChR2 | Bicuculline in area tempestus | Reduced seizure severity and frequency | Soper et al., 2015 |
Superior colliculus | hSyn | Panneuronal | ChR2 | GEPR‐3s (audiogenic seizure) | Reduced seizure severity and increased latency to onset | Soper et al., 2015 |
Superior colliculus | hSyn | Panneuronal | ChR2 | Systemic γ‐butyrolactone (absence seizures) | Reduced seizure frequency and duration | Soper et al., 2015 |
Hippocampus | Thy1 | Panneuronal | ChR2 | 4‐AP intrahippocampal | Seizure activity (signal power) during stimulation reduced but does not stop events | Ladas et al., 2015 |
Cerebellar nuclei | hSyn | Panneuronal | ChR2 | Tg mice spontaneous SWDs | Reduced number of SWD events | Kros et al., 2015 |
Cerebellar nuclei | hSyn | Panneuronal | ChR2 | C3H/HeOuJ mice spontaneous SWDs | Reduced number of SWD events | Kros et al., 2015 |
Dentate gyrus | Vgat | Interneurons | ChR2 | KA intrahippocampal SE | Reduced seizure frequency post‐KA and stopped seizure propagation to MEC and motor cortex | Lu et al., 2016 |
MEC | Vgat | Interneurons | ChR2 | KA intrahippocampal SE | Stopped seizure activity in MEC but did not stop seizure activity in dentate gyrus and M1 | Lu et al., 2016 |
Dentate gyrus | Gad | Interneurons | ChR2 | KA intrahippocampal SE | Reduced seizure frequency post‐KA and stopped seizure propagation to MEC and motor cortex | Lu et al., 2016 |
Dentate gyrus | Gad | Interneurons | NpHR | KA intrahippocampal SE | No effect on seizures | Lu et al., 2016 |
GEPR, genetically epilepsy‐prone rat; hSYN, human synapsin; KA, kainic acid; NpHR, halorhodopsin; Pcp2, purkinje cell protein 2; Pomc, proopiomelanocortin; PTZ, pentylenetetrazol; PV, parvalbumin; SE, status epilepticus; SWD, spike‐wave discharge; Thy1, thymocyte differentiation antigen 1; Vgat, vesicular GABA transporter.